The mechanisms of immune evasion of myeloma cells include the weak expression of tumor antigens, enhanced expression of inhibitory ligands (e.g., PD-L1), as well as increased numbers of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSC), which can inhibit CTL function. Here, CD274 is linked to plasma cell myeloma.